Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Apo-Pentoxifylline SR°


Contraindicated
Safety has not been established

Not recommended
Apo-Pentoxifylline SR° :
Type Medicine Withdrawn
Originator Trental Tablets
Agent Promopharm
Distributor Promopharm
Laboratory Apotex
Responsible Party Apotex Inc
Origin Canada
Manufacturer Apotex Inc
Manufacturing Type G
Origin Canada
ATC C04AD03

Your comment will appear shortly after approval

Apo-Pentoxifylline SR° :

Revision Date : 01/03/2011


Effect Frequency
Agitation Uncommon
Anaphylactic reactions Very rare
Anaphylactoid reactions Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Bronchospasm Very rare
Cephalea Uncommon
Diarrhoea (Diarrhea) Common
Failure circulatory Very rare
Flushing skin Common
Intrahepatic cholestatis Very rare
Nausea Common
Pruritus Uncommon
Sensation of fullness Common
Sensation of heat (Feeling of warmth) (Sensation of warmth) Common
Skin flushed Uncommon
Sleep disorder (Sleep disturbance) Uncommon
Stomach heaviness Common
Tachycardia Uncommon
Thrombocytopenia (Thrombopenia) Very rare
Transaminases increased Very rare
Urticaria Uncommon
Vertigo Uncommon
Vomiting Common

Different Units By MoH Code

Revision Date : 08/07/2017

Apo-Pentoxifylline SR°  MoH 5739 :
Form Tablet, sustained release
Packaging Bottle
Package Size Box of 100
Strength 400mg
NSSF ✘
Quarantine ✘
Reg. Number 219529/09
Submission date 01/01/2009
Registration Year 2010
Withdrawn Date 13/06/2024


Price Comparison

● Country: UK
● Package Size: 90
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Withdrawn

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info